Sinonasal disease is one of the most common clinical head and neck pathologies. The majority of sinonasal pathology is inflammatory with neoplasms comprising approximately 3% of all head and neck tumours. Although sinus tumours are rare, they portend a poor prognosis, often due to advanced disease at diagnosis. Like most neoplasms, early detection improves prognosis, therefore clinicians and radiologists should be aware of features separating tumours from inflammatory sinus disease. This article reviews the anatomy, clinical features, imaging findings, treatment and histopathology of selected sinonasal tumours. Benign neoplasms reviewed include osteoma, inverting papilloma, and juvenile nasal angiofibroma. Malignant neoplasms reviewed include squamous cell carcinoma, the minor salivary gland tumour, adenoid cystic carcinoma, adenocarcinoma, melanoma, lymphoma, and olfactory neuroblastoma (esthesioneuroblastoma).

Author

Sudip Das and Claudia F E Kirsch

Contact Details

Corresponding address:
C Kirsch MD,
Department of Neuroradiology,
Royal London Hospital,
Whitechapel Road,
E1 1BB, London, UK.

Reference

ICIS Cancer Imaging Volume 5 Issue 1
DOI: DOI: 10.1102/1470-7330.2005.0111

Date Posted

9 December 2005

Screen PDF

Size

816.23 KB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	3 seconds
ADSL 512Kb/s (Broadband):	12 seconds
64 Kb/s (ISDN):	1 minute 42 seconds
33.3 Kb/s (Typical Modem):	3 minutes 16 seconds

Print PDF

Size

16.94 MB

Minimum Estimated Download Times

ADSL 2Mb/s (Broadband):	1 minute 7 seconds
ADSL 512Kb/s (Broadband):	4 minutes 31 seconds
64 Kb/s (ISDN):	36 minutes 8 seconds
33.3 Kb/s (Typical Modem):	1 hour 9 minutes 27 seconds

No part of this publication or site may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior written permission of the Publisher, e-MED Limited, Permissions, PO Box 61053, London, SE16 7YZ. Tel: +44 (0)207 719 8989 Fax: +44 (0)560 126 4446, permissions@cancerimaging.org.